Switch to
View more

Ortin Laboratories Ltd

ORTINLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹19 cr, stock is ranked 3,099
High RiskStock is 3.61x as volatile as Nifty
23.650.80 (-3.27%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹19 cr, stock is ranked 3,099
High RiskStock is 3.61x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
-49.31
PB RatioPB Ratio
1.69
Dividend YieldDiv. Yield
Sector PESector PE
38.16
Sector PBSector PB
4.82
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Ortin Laboratories Limited is engaged in the business of manufacturing and trading of pharmaceuticals, drugs and intermediates.

Financial TrendFinancial statements 

2019202020212022167.89197.588.228.431.28-0.580.95-0.39
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Outcome of Board Meeting 
Announced OnAug 13, 2022

Ortin Laboratories Limited has informed the Exchange about Board Meeting held on 13-Aug-2022 to consider financial statements for the period ended June 2022 | Download

Ortin Laboratories Limited has informed the Exchange about Board Meeting held on 13-Aug-2022 to consider financial statements for the period ended June 2022 | Download

General updates 
Announced OnJul 9, 2022

Ortin Laboratories Limited has informed the Exchange about Compliance Certificate under Regulation 74(5) | Download

Ortin Laboratories Limited has informed the Exchange about Compliance Certificate under Regulation 74(5) | Download

Cash Dividend 
Ex. DateSep 24, 2013

Final • Div/Share: ₹ 0.25

See all events